Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference
A webcast of the fireside chat will be available on the investor page of the Harmony Biosciences website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa., we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Analog Devices Unlocks New Growth Engines In AI, Aerospace, And Robotics
Analog Devices (NASDAQ:ADI) delivered stronger-than-expected quarterly results on Wednesday and issued an upbeat outlook, signaling momentum across industrial and communications markets while highlighting new structural growth drivers in AI, aerospace, and automation. Following the results, JP Morgan analyst Harlan Sur maintained an Overweight rating on ADI and increased the price forecast from $300 to $310. Sur cited a stronger cyclical recovery and expanding secular drivers. He lifted his forward estimates, projecting fiscal 2026 EPS of ~$8.85, and applied a 35x multiple, the high end of peer group valuations, reflecting ADI's premium margins and diversified growth noted that July-quarter revenue rose 9% Q/Q to $2.88 billion, beating consensus of $2.765 billion, with EPS at $2.05 vs. $1.95 expected. Growth was broad-based: industrial climbed 11% Q/Q and 23% Y/Y, communications surged 18% Q/Q and 42% Y/Y on AI networking strength, and consumer rose 17% Q/Q and 20% Y/Y. Automotive stayed flat sequentially but gained 23% Y/Y due to product cycles and China demand pull-forward. For the October quarter, ADI guided revenue to $3.0 billion (up 4% Q/Q), topping consensus of $2.823 billion, with EPS of $2.22 vs. $2.03 expected and operating margin of 43.5% vs. 42.4% consensus. Industrial is expected to lead growth with low-to-mid-teens sequential gains, while automotive should decline in the low-teens Q/Q as earlier pull-forwards unwind. Sur highlighted ADI's structural growth engines, including aerospace & defense now trending above $1 billion annually (~10% of revenue), AI/datacenter opportunities in optical networking and power systems rising toward $550 million–$600 million annually vs. $400 million in fiscal 2024, and industrial automation tailwinds from humanoid robotics design wins. Sur also cited strong capital returns, with $3.7 billion in free cash flow (35% margin) over the past 12 months and $1.6 billion returned to shareholders via dividends and buybacks. Price Action: ADI stock is trading higher by 1.73% to $249.04 at last check Thursday. Photo via Shutterstock Latest Ratings for ADI Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Citigroup Maintains Buy Jan 2022 Barclays Maintains Overweight View More Analyst Ratings for ADI View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? ANALOG DEVICES (ADI): Free Stock Analysis Report This article Analog Devices Unlocks New Growth Engines In AI, Aerospace, And Robotics originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
21 minutes ago
- Yahoo
Futu Holdings (FUTU) Ends 4-Day Losses on Stellar Earnings
We recently published . Futu Holdings Limited (NASDAQ:FUTU) is one of Wednesday's best performers. Futu Holdings snapped a four-day losing streak on Wednesday, jumping 6.01 percent to close at $178.66 apiece as investors cheered the company's stellar earnings performance in the second quarter of the year. In an updated report, Futu Holdings Limited (NASDAQ:FUTU) said net income more than doubled to HK$2.57 billion from HK$1.21 billion in the same period last year. Revenues grew by 69 percent to HK$5.3 billion from HK$3.13 billion year-on-year, on the back of higher brokerage commission and handling charge income, as well as increased interest income. Copyright: belchonock / 123RF Stock Photo In the first half, net income more than doubled to HK$4.7 billion from HK$2.24 billion, while revenues increased by 75 percent to HK$10 billion from HK$5.7 billion year-on-year. 'Trade policy-induced market volatility, coupled with a slate of high-profile IPOs, boosted retail sentiment in Hong Kong, which, for the third quarter in a row, contributed the highest number of new funded accounts across all markets. The US market also recorded solid growth. In the second quarter, we became the official sponsor of the New York Mets, further elevating our brand image in the US and beyond. We also launched crypto trading in most of the states in June, strengthening our value proposition as a one-stop trading platform,' said Futu Holdings Limited (NASDAQ:FUTU) Chairman and CEO Leaf Hua Li. While we acknowledge the potential of FUTU as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Yahoo
21 minutes ago
- Yahoo
Analog Devices (ADI) Soars as Earnings Impress
We recently published . Analog Devices, Inc. (NASDAQ:ADI) is one of Wednesday's best performers. Analog Devices jumped by 6.26 percent on Wednesday to close at $244.87 apiece following an impressive earnings performance in the third quarter of fiscal year 2025. In an updated report, Analog Devices, Inc. (NASDAQ:ADI) said net income increased by 32 percent to $518 million from $392 million in the same period last year. Revenues grew by 25 percent to $2.88 billion from $2.3 billion year-on-year. source: pixabay For the nine-month period, net income jumped by 28 percent to $1.479 billion from $1.157 billion year-on-year, while revenues rose by 13 percent to $7.9 billion from $6.98 billion in the same comparable period. For the fourth quarter of the fiscal year period, Analog Devices, Inc. (NASDAQ:ADI) said it expects to rake in $3 billion in revenues, plus or minus $100 million. Lastly, its board of directors approved the distribution of $0.99 in cash dividends for each common share held as of September 2. The dividends are payable on September 16, 2025. While we acknowledge the potential of ADI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
